Skip to main content

Table 4 Summary of rickettsiae-seropositive and seronegative cases and patients, Ontario, Canada (2013–2018)

From: Assessing human exposure to spotted fever and typhus group rickettsiae in Ontario, Canada (2013–2018): a retrospective, cross-sectional study

Variable

Seropositive cases

Seronegative patients

Total, n

626

2129

Female, n (%)

297 (47.4)

1253 (58.8)

Age, mean ± SE (range)a

42.9 ± 0.76 (<  1–89)

43.0 ± 0.40 (<  1–90)

Sera samples/patient, mean ± SE (range)b

1.3 ± 0.026 (1–7)

1.1 ± 0.0067 (1–4)

Year of onset, n

 2013

41

276

 2014

49

279

 2015

69

275

 2016

76

413

 2017

164

465

 2018

227

421

Signs and symptoms, n (%)c

None reported

387 (61.8)

1361 (63.9)

 Headache

134 (54.0)

263 (33.1)

 Fever

75 (30.2)

253 (31.8)

 Fatigue

65 (26.2)

225 (28.3)

 Gastrointestinal complaints

27 (10.9)

86 (10.8)

 Respiratory complaints

21 (8.5)

59 (7.4)

 Arthralgia/arthritis

19 (7.7)

65 (8.2)

 Rash (maculopapular)

15 (6.0)

79 (9.9)

 Rash (not described)

13 (5.2)

51 (6.4)

 Tick bite

13 (5.2)

46 (5.8)

 Encephalitis/meningitis

12 (4.8)

23 (2.9)

 Rash (vesicular)

10 (4.0)

27 (3.4)

 Malaise/unwell

9 (3.6)

5 (0.6)

 Myalgia/body aches

7 (2.8)

10 (1.3)

 Chills

2 (0.8)

8 (1.0)

 Elevated liver enzymes

2 (0.8)

7 (0.9)

 Jaundice

2 (0.8)

5 (0.6)

 Anemia

1 (0.4)

2 (0.3)

 Anxiety

1 (0.4)

2 (0.3)

 Dizziness

1 (0.4)

5 (0.6)

 Confusion

0 (0.0)

2 (0.3)

 Hepatitis

0 (0.0)

2 (0.3)

 Edema

0 (0.0)

1 (0.1)

  1. Abbreviations: n/a not applicable
  2. a Sex of some patients was not available
  3. bt = 7.3, df = 706, p < 0.0001
  4. c Cases and patients reporting at least one sign or symptom: seropositive, n = 239; seronegative, n = 768. Some cases and patients have > 1 sign or symptom. Denominator is based on number of cases or patients with at least one symptom reported on the requisition